SMPD1 and Alzheimer disease: Therefore, increased ASM activity in AD contributes to brain pathology through abnormal autophagic degradation, and restoration of ASM effectively blocks AD progression by ameliorating autophagy, suggesting that ASM inhibition is a potential new therapeutic intervention for AD patients.